Kishino, Yoshikazu
Fujita, Jun
Tohyama, Shugo
Okada, Marina
Tanosaki, Sho
Someya, Shota
Fukuda, Keiichi
Funding for this research was provided by:
the Highway Program for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19bk0104062h0003)
a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (19H03660)
a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (17H05067)
Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine by Japan, the Japan Agency for Medical Research and Development (19bm0404023h0002)
Japan Society for the Promotion of Science (17H05067)
Article History
Received: 19 July 2019
Accepted: 19 December 2019
First Online: 13 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JF, ST, and KF own equity in Heartseed, Inc. KF is the CEO of Heartseed, Inc. and receives a salary from Heartseed, Inc. YK, MO, STanosaki, and SS have no conflicts of interest to declare.